Format

Send to

Choose Destination
Am J Cardiol. 2015 Aug 1;116(3):420-5. doi: 10.1016/j.amjcard.2015.04.057. Epub 2015 May 9.

Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry).

Author information

1
Department of Cardiology, Brest University, Brest, France.
2
Department of Cardiology, Rouen University, Rouen, France.
3
Department of Cardiology, Bichat University, Paris, France.
4
Department of Cardiac Surgery, Massy Hospital, Massy, France.
5
UMR 1123, Creteil University, Creteil, France.
6
Department of Cardiology, Pasteur Hospital, Toulouse, France.
7
Department of Cardiology, Rennes University, Rennes, France.
8
UMR CNRS 5558, Lyon University, Lyon, France.
9
Departement of Cardiac Surgery, Lille University, Lille, France.
10
Departement of Cardiac Surgery, Limoges University, Limoges, France.
11
Department of Cardiology, Brest University, Brest, France. Electronic address: martine.gilard@chu-brest.fr.

Abstract

Previous coronary artery bypass grafting (CABG) increases operative risk in conventional valve replacement. Transcatheter aortic valve implantation (TAVI) has been shown to be successful in high-risk patient subgroups. The present study compared outcome and overall survival in patients who underwent TAVI with and without history of CABG. From January 2010 to December 2011, 683 of the 3,761 patients selected for TAVI in 34 French centers (18%) had a history of CABG. Outcomes (mortality and complications) were collected prospectively according to the Valve Academic Research Consortium (VARC) criteria. Patients with previous CABG were younger, with higher rates of diabetes and vascular disease and higher logistic European System for Cardiac Operative Risk Evaluation (29.8 ± 16.4 vs 20.1 ± 13.0, p <0.001) but lower rates of pulmonary disease. Two types of valve (Edwards SAPIEN and Medtronic CoreValve) were implanted in equal proportions in the 2 groups. The 30-day and 1-year mortality rates from all causes on Kaplan-Meier analysis (9.2% vs 9.7%, p = 0.71; and 19.0% vs 20.2%, p = 0.49, respectively) did not differ according to the history of CABG. There were no significant differences in the Valve Academic Research Consortium complications (myocardial infarction, stroke or vascular, and bleeding complications). On multivariate analysis, CABG was not associated with greater 1-year post-TAVI mortality. In conclusion, previous CABG did not adversely affect outcome in patients who underwent TAVI, which may be an alternative to surgery in high-risk patients with severe aortic stenosis and history of CABG.

PMID:
26071993
DOI:
10.1016/j.amjcard.2015.04.057
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center